Edwards Lifesciences Corporation Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
Edwards Lifesciences Corporation (EW) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $11.60 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-08-04
- Edwards Lifesciences Corporation right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-06-30 was $8.00M, a 45.45% increase year-over-year.
- Edwards Lifesciences Corporation right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-03-31 was $3.60M, a 12.50% increase year-over-year.
- Edwards Lifesciences Corporation right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-12-31 was $12.70M, a 225.64% increase year-over-year.
- Edwards Lifesciences Corporation right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-09-30 was $4.60M, a 67.83% decline year-over-year.
- Edwards Lifesciences Corporation right-of-use asset obtained in exchange for operating lease liability for fiscal 2025 was $26.00M, a 39.25% decline from fiscal 2024.
- Edwards Lifesciences Corporation right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $42.80M, a 56.78% increase from fiscal 2023.
- Edwards Lifesciences Corporation right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $27.30M, a 16.67% increase from fiscal 2022.
- Edwards Lifesciences Corporation right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $23.40M, a 18.47% decline from fiscal 2021.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month as first filed | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month as first filed | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month as first filed | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $8.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $11.60M 10-Q · filed 2026-08-04 | $24.30M derived: sum of 3 quarters · filed 2026-08-04 | $28.90M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | $3.60M 10-Q · filed 2026-05-06 | $16.30M derived: sum of 2 quarters · filed 2026-05-06 | $20.90M derived: sum of 3 quarters · filed 2026-05-06 | $26.40M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | $12.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $17.30M derived: sum of 2 quarters · filed 2026-02-25 | $22.80M derived: sum of 3 quarters · filed 2026-08-04 | $26.00M 10-K · filed 2026-02-25 | ||||
| 2025-09-30 | $4.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $10.10M derived: sum of 2 quarters · filed 2026-08-04 | $13.30M 10-Q · filed 2025-11-05 | $17.20M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | $5.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $8.70M 10-Q · filed 2026-08-04 | $12.60M derived: sum of 3 quarters · filed 2026-08-04 | $26.90M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | $3.20M 10-Q · filed 2026-05-06 | $7.10M derived: sum of 2 quarters · filed 2026-05-06 | $21.40M derived: sum of 3 quarters · filed 2026-05-06 | $38.30M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | $3.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $18.20M derived: sum of 2 quarters · filed 2026-02-25 | $35.10M derived: sum of 3 quarters · filed 2026-02-25 | $42.80M 10-K · filed 2026-02-25 | ||||
| 2024-09-30 | $14.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $31.20M derived: sum of 2 quarters · filed 2025-11-05 | $38.90M 10-Q · filed 2025-11-05 | $46.30M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-06-30 | $16.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $24.60M 10-Q · filed 2025-08-06 | $32.00M derived: sum of 3 quarters · filed 2026-02-25 | $46.70M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-03-31 | $7.70M 10-Q · filed 2025-05-06 | $13.40M 10-Q · filed 2024-04-29 | $15.10M derived: sum of 2 quarters · filed 2026-02-25 | $29.80M derived: sum of 3 quarters · filed 2026-02-25 | $32.80M derived: sum of 4 quarters · filed 2026-02-25 | |||
| 2023-12-31 | $7.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $22.10M derived: sum of 2 quarters · filed 2026-02-25 | $25.10M derived: sum of 3 quarters · filed 2026-02-25 | $27.30M 10-K · filed 2026-02-25 | $29.30M 10-K · filed 2024-02-12 | |||
| 2023-09-30 | $14.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $17.70M derived: sum of 2 quarters · filed 2024-11-06 | $19.90M 10-Q · filed 2024-11-06 | $21.20M 10-Q · filed 2023-10-27 | $18.60M derived: sum of 4 quarters · filed 2025-02-28 | |||
| 2023-06-30 | $3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $5.20M 10-Q · filed 2024-07-31 | $6.00M 10-Q · filed 2023-07-28 | $3.90M derived: sum of 3 quarters · filed 2025-02-28 | $18.00M derived: sum of 4 quarters · filed 2025-02-28 | |||
| 2023-03-31 | $2.20M 10-Q · filed 2024-04-29 | $900.00K derived: sum of 2 quarters · filed 2025-02-28 | $15.00M derived: sum of 3 quarters · filed 2025-02-28 | $19.20M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2022-12-31 | -$1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $12.80M derived: sum of 2 quarters · filed 2025-02-28 | $17.00M derived: sum of 3 quarters · filed 2025-02-28 | $23.40M 10-K · filed 2025-02-28 | $31.90M 10-K · filed 2023-02-13 | |||
| 2022-09-30 | $14.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-27 | $18.30M derived: sum of 2 quarters · filed 2023-10-27 | $24.70M 10-Q · filed 2023-10-27 | $39.90M derived: sum of 4 quarters · filed 2024-02-12 | ||||
| 2022-06-30 | $4.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-28 | $10.60M 10-Q · filed 2023-07-28 | $25.80M derived: sum of 3 quarters · filed 2024-02-12 | $33.90M derived: sum of 4 quarters · filed 2024-02-12 | ||||
| 2022-03-31 | $6.40M 10-Q · filed 2023-04-28 | $21.60M derived: sum of 2 quarters · filed 2024-02-12 | $29.70M derived: sum of 3 quarters · filed 2024-02-12 | $31.60M derived: sum of 4 quarters · filed 2024-02-12 | ||||
| 2021-12-31 | $15.20M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-12 | $23.30M derived: sum of 2 quarters · filed 2024-02-12 | $25.20M derived: sum of 3 quarters · filed 2024-02-12 | $28.70M 10-K · filed 2024-02-12 | ||||
| 2021-09-30 | $8.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | $10.00M derived: sum of 2 quarters · filed 2022-10-28 | $13.50M 10-Q · filed 2022-10-28 | $22.50M derived: sum of 4 quarters · filed 2023-02-13 | ||||
| 2021-06-30 | $1.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-29 | $5.40M 10-Q · filed 2022-07-29 | $14.40M derived: sum of 3 quarters · filed 2023-02-13 | $25.60M derived: sum of 4 quarters · filed 2023-02-13 | ||||
| 2021-03-31 | $3.50M 10-Q · filed 2022-04-28 | $12.50M derived: sum of 2 quarters · filed 2023-02-13 | $23.70M derived: sum of 3 quarters · filed 2023-02-13 | $38.70M derived: sum of 4 quarters · filed 2023-02-13 | ||||
| 2020-12-31 | $9.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-13 | $20.20M derived: sum of 2 quarters · filed 2023-02-13 | $35.20M derived: sum of 3 quarters · filed 2023-02-13 | $39.70M 10-K · filed 2023-02-13 | ||||
| 2020-09-30 | $11.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29 | $26.20M derived: sum of 2 quarters · filed 2021-10-29 | $30.70M 10-Q · filed 2021-10-29 | $47.10M derived: sum of 4 quarters · filed 2022-02-14 | ||||
| 2020-06-30 | $15.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $19.50M 10-Q · filed 2021-07-30 | $35.90M derived: sum of 3 quarters · filed 2022-02-14 | $45.60M derived: sum of 4 quarters · filed 2022-02-14 | ||||
| 2020-03-31 | $4.50M 10-Q · filed 2021-04-28 | $20.90M derived: sum of 2 quarters · filed 2022-02-14 | $30.60M derived: sum of 3 quarters · filed 2022-02-14 | $37.80M derived: sum of 4 quarters · filed 2022-02-14 | ||||
| 2019-12-31 | $16.40M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-14 | $26.10M derived: sum of 2 quarters · filed 2022-02-14 | $33.30M derived: sum of 3 quarters · filed 2022-02-14 | $49.60M 10-K · filed 2022-02-14 | ||||
| 2019-09-30 | $9.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-26 | $16.90M derived: sum of 2 quarters · filed 2020-10-26 | $33.20M 10-Q · filed 2020-10-26 | $33.20M derived: sum of 4 quarters · filed 2021-02-12 | ||||
| 2019-06-30 | $7.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-27 | $23.50M 10-Q · filed 2020-07-27 | $23.50M derived: sum of 3 quarters · filed 2021-02-12 | $23.50M derived: sum of 4 quarters · filed 2021-02-12 | ||||
| 2019-03-31 | $16.30M 10-Q · filed 2020-04-28 | $16.30M derived: sum of 2 quarters · filed 2021-02-12 | $16.30M derived: sum of 3 quarters · filed 2021-02-12 | $16.30M derived: sum of 4 quarters · filed 2021-02-12 | ||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | $0.00 derived: sum of 2 quarters · filed 2021-02-12 | $0.00 derived: sum of 3 quarters · filed 2021-02-12 | $0.00 10-K · filed 2021-02-12 | ||||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-25 | $0.00 derived: sum of 2 quarters · filed 2019-10-25 | $0.00 10-Q · filed 2019-10-25 | |||||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-26 | $0.00 10-Q · filed 2019-07-26 | ||||||
| 2018-03-31 | $0.00 10-Q · filed 2019-04-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |